Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Recruiting · NCT04915183 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer | Ear Diseases, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, carcinoma, epithelial neoplasm, head and neck cancer, hearing disorder, hearing loss disorder, neoplasm, nervous system disorder, otorhinolaryngologic disease, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2026-09-02 | NCT04915183 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute on Deafness and Other Communication Disorders (NIDCD) | 187 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Inova Schar Cancer Center | Fairfax | United States | 2 |
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |
| University of Maryland Medical Center | Baltimore | United States | 87 |
| Wilmot Cancer Institute at the University of Rochester Medical Center in New Yor | Rochester | United States | 1 |
| Winship Cancer Institute At Emory University | Atlanta | United States | 10 |